HealthInvest Partners AB »

Autolus Therapeutics Plc spon ads shares owned by HealthInvest Partners AB

Quarter-by-quarter ownership of Autolus Therapeutics Plc spon ads (AUTL) shares owned by HealthInvest Partners AB from 13F filings

Historical chart of HealthInvest Partners AB investment in Autolus Therapeutics Plc spon ads

Tip: Access up to 7 years of quarterly data

All positions including Autolus Therapeutics Plc spon ads held by HealthInvest Partners AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Autolus Therapeutics Plc spon ads by HealthInvest Partners AB

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.6M 442k 3.63
2024-03-31 $615k 96k 6.38
2023-12-31 $621k 96k 6.44

More positions owned by HealthInvest Partners AB

Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
Merck & Co (MRK)
Thermo Fisher Scientific (TMO)
Amgen (AMGN)
Boston Scientific Corporation (BSX)
Abbvie (ABBV)
Stryker Corporation (SYK)
AmerisourceBergen (COR)
Vertex Pharmaceuticals Incorporated (VRTX)
Regeneron Pharmaceuticals (REGN)
Neurocrine Biosciences (NBIX)
Alkermes SHS (ALKS)
Intra Cellular Therapies (ITCI)
Harmony Biosciences Hldgs In (HRMY)

View all positions for HealthInvest Partners AB

Top funds holding Autolus Therapeutics Plc spon ads

Syncona Portfolio
Blackstone Group
Deep Track Capital
Polygon Management
Armistice Capital
Frazier Life Sciences Management
Affinity Asset Advisors
BlackRock
BlackRock
T. Rowe Price Associates
Deerfield Management Company
Laurion Capital Management
Morgan Stanley
Dr. Jeffrey R. Jay, M.D.
Stempoint Capital

View all funds holding Autolus Therapeutics Plc spon ads